Display options
Share it on

Oncotarget. 2017 Dec 20;9(8):7832-7843. doi: 10.18632/oncotarget.23471. eCollection 2018 Jan 30.

Rapid detection of .

Oncotarget

Ava Kwong, John C W Ho, Vivian Y Shin, Allison W Kurian, Edmund Tai, Laura J Esserman, Jeffery N Weitzel, Po-Han Lin, Michael Field, Susan M Domchek, Jessica Lo, Hextan Y S Ngan, Edmond S K Ma, Tsun L Chan, James M Ford

Affiliations

  1. Department of Surgery, The University of Hong Kong, Hong Kong, China.
  2. Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong, China.
  3. Department of Surgery, Hong Kong Sanatorium & Hospital, Hong Kong, China.
  4. Department of Medicine, Health Research & Policy and Genetics, Stanford University School of Medicine, Stanford, CA, United States.
  5. Palo Alto Medical Foundation, Palo Alto, CA, United States.
  6. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, United States.
  7. Division of Clinical Cancer Genomics, City of Hope, Duarte, CA, United States.
  8. Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan.
  9. Department of Clinical Genetics, Royal North Shore Hospital, St Leonards, NSW, Australia.
  10. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.
  11. Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, China.
  12. Department of Molecular Pathology, Hong Kong Sanatorium & Hospital, Hong Kong, China.

PMID: 29487695 PMCID: PMC5814262 DOI: 10.18632/oncotarget.23471

[No abstract available.]

Keywords: BRCA1/2; breast cancer; genetic testing; mutation; ovarian cancer

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest.

References

  1. Breast Cancer Res Treat. 2016 Jun;157(2):211-215 - PubMed
  2. PLoS One. 2012;7(9):e43994 - PubMed
  3. Cancer Genet. 2015 Sep;208(9):448-54 - PubMed
  4. Breast Cancer Res Treat. 2012 Apr;132(2):421-8 - PubMed
  5. Public Health Genomics. 2016;19(1):53-60 - PubMed
  6. Am J Hum Genet. 1997 May;60(5):1059-67 - PubMed
  7. Bioinformatics. 2014 Oct 15;30(20):2843-51 - PubMed
  8. J Epidemiol. 2013;23(2):75-84 - PubMed
  9. Breast Cancer Res Treat. 2008 Jul;110(1):99-109 - PubMed
  10. Lancet Oncol. 2014 Jul;15(8):852-61 - PubMed
  11. EPMA J. 2010 Sep;1(3):397-412 - PubMed
  12. Bioinformatics. 2009 Aug 15;25(16):2078-9 - PubMed
  13. J Natl Cancer Inst. 2001 Nov 7;93(21):1633-7 - PubMed
  14. CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32 - PubMed
  15. J Cancer Res Clin Oncol. 2006 Oct;132(10):617-26 - PubMed
  16. Nat Genet. 2011 May;43(5):491-8 - PubMed
  17. Hum Mutat. 2002 Mar;19(3):307-8 - PubMed
  18. Oncogene. 2006 Sep 25;25(43):5825-31 - PubMed
  19. N Engl J Med. 2002 May 23;346(21):1616-22 - PubMed
  20. Cancer Genet. 2016 Sep;209(9):417-422 - PubMed
  21. J Clin Oncol. 2008 Oct 10;26(29):4752-8 - PubMed
  22. Breast Cancer Res Treat. 2012 Dec;136(3):931-3 - PubMed
  23. J Clin Oncol. 2015 Jun 10;33(17):1902-9 - PubMed
  24. Breast Cancer Res Treat. 2016 Oct;159(3):395-406 - PubMed
  25. J Breast Cancer. 2013 Dec;16(4):357-65 - PubMed
  26. JAMA Oncol. 2015 Oct;1(7):943-51 - PubMed
  27. Bioinformatics. 2010 Aug 15;26(16):2069-70 - PubMed
  28. Hum Genet. 1999 Mar;104(3):201-4 - PubMed
  29. Nat Genet. 1996 Oct;14(2):185-7 - PubMed
  30. J Mol Diagn. 2016 Jul;18(4):580-94 - PubMed

Publication Types